Chimaobi Jude Nwiyi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chimaobi Jude Nwiyi has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Victor Chikaodiri Amaechi
Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nsukka, Nigeria
3 shared publications - Evaristus Chinonso Odoh
University of Nigeria, Nigeria
2 shared publications - Evaristus Jideofor Ugboma
Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria Nsukka, Nigeria
2 shared publications - Fadilulahi Ayokunle Usman
Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
2 shared publications - Gerald Obinna Ozota
Department of Pharmacy, Federal Neuropsychiatric Hospital Yaba, Lagos
2 shared publications - Joy Chekwube Onyesoro
Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nsukka, Enugu State, Nigeria
2 shared publications
Latest Publications
- Open Access
- 24 January 2025
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 25 (1) , 478-492
Knowledge, attitude, and practice of pharmacists in Southern Nigeria towards management and prevention of hepatitis B virus
Introduction: This study assessed the attitude and awareness of pharmacists in Southern Nigeria towards management and prevention of hepatitis B infection. Methods: A 39-item, structured questionnaire was distributed online via WhatsApp groups of the Pharmaceutical Society of Nigeria (PSN) technical groups in 17 Southern Nigerian states for 6 weeks (August to September 2024). Data from 255 responses were analysed using SPSS v22, with statistical significance set at P ≤0.05. Results: All respondents (100%) were aware of hepatitis B. Most (95.7%) knew that the virus could be transmitted via blood and blood products, and 73.7% knew that it could be transmitted from mother to child. In addition, 63.1 % identified Hepatitis B as a nosocomial infection and 96.1% knew about the availability of hepatitis B vaccine. Screening for hepatitis B was reported by 59.6%, whereas 48.6% had received formal training focused on hepatitis B. However, only 37.3% had been vaccinated, and 55.3% were unvaccinated. Conclusion: The study revealed that the respondents have good knowledge, awareness, and attitude towards the management and prevention of hepatitis B. However, this did not translate into optimal preventive practices. Specific training on hepatitis B should be incorporated into continuous professional development programs for pharmacists.
- 24 January 2025
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 25 (1) , 478-492
Open AccessKnowledge, attitude, and practice of pharmacists in Southern Nigeria towards management and prevention of hepatitis B virus
Introduction: This study assessed the attitude and awareness of pharmacists in Southern Nigeria towards management and prevention of hepatitis B infection. Methods: A 39-item, structured questionnaire was distributed online via WhatsApp groups of the Pharmaceutical Society of Nigeria (PSN) technical groups in 17 Southern Nigerian states for 6 weeks (August to September 2024). Data from 255 responses were analysed using SPSS v22, with statistical significance set at P ≤0.05. Results: All respondents (100%) were aware of hepatitis B. Most (95.7%) knew that the virus could be transmitted via blood and blood products, and 73.7% knew that it could be transmitted from mother to child. In addition, 63.1 % identified Hepatitis B as a nosocomial infection and 96.1% knew about the availability of hepatitis B vaccine. Screening for hepatitis B was reported by 59.6%, whereas 48.6% had received formal training focused on hepatitis B. However, only 37.3% had been vaccinated, and 55.3% were unvaccinated. Conclusion: The study revealed that the respondents have good knowledge, awareness, and attitude towards the management and prevention of hepatitis B. However, this did not translate into optimal preventive practices. Specific training on hepatitis B should be incorporated into continuous professional development programs for pharmacists.
- Open Access
- 12 October 2024
- Published by Sciencedomain International in Asian Journal of Advanced Research and Reports
- Vol. 18 (11) , 74-86
Accessibility and Inclusivity of Chimeric Antigen Receptor T-cell Immunotherapy in Treating Hematological Malignancies
Targeting the molecule cluster of differentiation 19 (CD19), chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell therapy now used in clinical practice for hematological malignancies. Studies on CAR-T-cell therapy have shown that it is highly effective, with high objective response rates (ORRs) and, in certain cases, promising progression-free survival (PFS). Notwithstanding, impediments can arise because of the emergence of resistance mechanisms, including the loss of CD19 antigen and immune suppression caused by the tumor microenvironment. Immune checkpoint inhibitors, allogeneic CAR-T cell treatment, and sequential CAR-T cell therapy are methods employed to overcome these barriers. Research on the use of CAR-T-cell therapy for T-cell malignancies and other disorders is still underway, despite the treatment's impressive results in treating B-cell malignancies. The therapy's high purchase cost and the lack of conclusive clinical proof make cost-effectiveness difficult to achieve. The scarcity of specialist facilities providing CAR-T therapy further impedes access, necessitating patients to surmount logistical and financial obstacles. To increase accessibility and affordability and to ascertain its long-term cost-effectiveness, more thorough investigations are required. CAR T-cell immunotherapy has a bright future ahead of it but to be used more widely and fairly, several important issues must be resolved. This review paper aims to assess critically the current accessibility and inclusivity of CAR T cell immunotherapy, identifying barriers and opportunities to enhance its application in the treatment of hematological malignancies.
- 12 October 2024
- Published by Sciencedomain International in Asian Journal of Advanced Research and Reports
- Vol. 18 (11) , 74-86
Open AccessAccessibility and Inclusivity of Chimeric Antigen Receptor T-cell Immunotherapy in Treating Hematological Malignancies
Targeting the molecule cluster of differentiation 19 (CD19), chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell therapy now used in clinical practice for hematological malignancies. Studies on CAR-T-cell therapy have shown that it is highly effective, with high objective response rates (ORRs) and, in certain cases, promising progression-free survival (PFS). Notwithstanding, impediments can arise because of the emergence of resistance mechanisms, including the loss of CD19 antigen and immune suppression caused by the tumor microenvironment. Immune checkpoint inhibitors, allogeneic CAR-T cell treatment, and sequential CAR-T cell therapy are methods employed to overcome these barriers. Research on the use of CAR-T-cell therapy for T-cell malignancies and other disorders is still underway, despite the treatment's impressive results in treating B-cell malignancies. The therapy's high purchase cost and the lack of conclusive clinical proof make cost-effectiveness difficult to achieve. The scarcity of specialist facilities providing CAR-T therapy further impedes access, necessitating patients to surmount logistical and financial obstacles. To increase accessibility and affordability and to ascertain its long-term cost-effectiveness, more thorough investigations are required. CAR T-cell immunotherapy has a bright future ahead of it but to be used more widely and fairly, several important issues must be resolved. This review paper aims to assess critically the current accessibility and inclusivity of CAR T cell immunotherapy, identifying barriers and opportunities to enhance its application in the treatment of hematological malignancies.
- Open Access
- 14 September 2024
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
THE IMPACT OF DRUG COST ON MEDICATION ADHERENCE IN NIGERIA: A PERCEPTION AMONG PHARMACISTS
Background: Given Nigeria's huge economic instability, medication expenses may significantly impact medication adherence, creating a barrier to the treatment of various ailments. The study aimed to assess pharmacists' perceptions about the impact of drug costs on medication adherence in Nigeria. Methods: The study was cross-sectional among practicing pharmacists across Nigeria. The 25 items semi-structured questionnaire was administered online using simple random sampling with the snowballing technique to recruit the pharmacists for the study. The collected data was coded into Microsoft Excel 2016 and subsequently analyzed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were utilized to summarize the data, providing an overview of the demographic characteristics and key findings. Inferential statistics, specifically Pearson’s Chi-square test, were employed where applicable to determine the relationships between variables. Results: Total 161 pharmacists responded to the survey, giving an 80.5% response rate. The respondent rate was mainly young pharmacists (20–30 years old; 82.6%) and predominantly male (51.6%). Almost all the respondents possess only a bachelor of pharmacy degree (91.9%). Total 90% have practiced for 5 years or less, mostly in community settings (60.9%). Generic substitution has been cited as the most important technique to manage drug costs. Non-adherence due to cost was associated with practice settings, whereas adherence counseling was correlated with gender and setting of practice. All differences were not statistically significant at p<0.05. Conclusions: Most participants believe that the cost of medication is a major barrier to accessing quality healthcare and drives massive non-adherence among those who can barely afford the medicines. Implementing a comprehensive national strategy to enhance the healthcare system, expand the reach of the national health insurance program, and promote cooperation among healthcare practitioners will result in improved clinical outcomes for patients. Peer Review History: Received 22 May 2024; Revised 11 July 2024; Accepted 26 August; Available online 15 September 2024 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewers: Prof. Hassan A.H. Al-Shamahy, Sana'a University, Yemen, shmahe@yemen.net.ye Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, sansan4240732@163.com
- 14 September 2024
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessTHE IMPACT OF DRUG COST ON MEDICATION ADHERENCE IN NIGERIA: A PERCEPTION AMONG PHARMACISTS
Background: Given Nigeria's huge economic instability, medication expenses may significantly impact medication adherence, creating a barrier to the treatment of various ailments. The study aimed to assess pharmacists' perceptions about the impact of drug costs on medication adherence in Nigeria. Methods: The study was cross-sectional among practicing pharmacists across Nigeria. The 25 items semi-structured questionnaire was administered online using simple random sampling with the snowballing technique to recruit the pharmacists for the study. The collected data was coded into Microsoft Excel 2016 and subsequently analyzed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were utilized to summarize the data, providing an overview of the demographic characteristics and key findings. Inferential statistics, specifically Pearson’s Chi-square test, were employed where applicable to determine the relationships between variables. Results: Total 161 pharmacists responded to the survey, giving an 80.5% response rate. The respondent rate was mainly young pharmacists (20–30 years old; 82.6%) and predominantly male (51.6%). Almost all the respondents possess only a bachelor of pharmacy degree (91.9%). Total 90% have practiced for 5 years or less, mostly in community settings (60.9%). Generic substitution has been cited as the most important technique to manage drug costs. Non-adherence due to cost was associated with practice settings, whereas adherence counseling was correlated with gender and setting of practice. All differences were not statistically significant at p<0.05. Conclusions: Most participants believe that the cost of medication is a major barrier to accessing quality healthcare and drives massive non-adherence among those who can barely afford the medicines. Implementing a comprehensive national strategy to enhance the healthcare system, expand the reach of the national health insurance program, and promote cooperation among healthcare practitioners will result in improved clinical outcomes for patients. Peer Review History: Received 22 May 2024; Revised 11 July 2024; Accepted 26 August; Available online 15 September 2024 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewers: Prof. Hassan A.H. Al-Shamahy, Sana'a University, Yemen, shmahe@yemen.net.ye Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, sansan4240732@163.com
- 9 September 2024
- Published by Sciencedomain International in Asian Journal of Research in Medical and Pharmaceutical Sciences
- Vol. 13 (4) , 61-73
Assessing Socioeconomic Disparities and Health Outcomes among Cancer Patients in a Nigerian Teaching Hospital
Background: Cancer affects all population groups in the Nigeria, but due to social, environmental, and economic disadvantages, certain groups bear a different burden of cancer. Disparities in health among populations account for preventable morbidity and mortality. Research in this area is focused on identifying health disparities and outcomes contributing to overall wellbeing. Different groups may experience cancer disparities and these groups can be defined by age, gender, education, ethnicity, income, race, origin, and other characteristics. Health disparities can affect cancer outcomes, from diagnosis to treatment. This study evaluates the health disparities and outcomes of cancer patients in a Nigerian Teaching Hospital. Methods: This is a descriptive cross-sectional study using a structured questionnaire among patients visiting the oncology unit in the hospital. The questionnaire was interviewer- administered. Descriptive statistics was used to present respondents’ sociodemographic characteristics. Pearson correlation test was used to determine relationship between the determinant of cancer disparity (social demographics) and the outcomes (from patient perspective). Results: A total of 150 patients participated in the study. More female respondents (70%) than male respondents (45%), mostly within the age range of 62 and above (56.7%) participated in this study. The disparities examined include: age, gender, marital status, educational level, occupatina, montly income, religion and health insurance. There was a correlation between the different disparities and health outcomes. All disparities except gender were statistically significant (P = 0.05 & 0.01). Age, marital status, occupation status, religion and health insurance associated postively, while educational level and monthly income associated negatively. Gender had no associaton at all. Overall, patients (50%) were a little satisfied with the overall health outcomes.
- 9 September 2024
- Published by Sciencedomain International in Asian Journal of Research in Medical and Pharmaceutical Sciences
- Vol. 13 (4) , 61-73
Assessing Socioeconomic Disparities and Health Outcomes among Cancer Patients in a Nigerian Teaching Hospital
Background: Cancer affects all population groups in the Nigeria, but due to social, environmental, and economic disadvantages, certain groups bear a different burden of cancer. Disparities in health among populations account for preventable morbidity and mortality. Research in this area is focused on identifying health disparities and outcomes contributing to overall wellbeing. Different groups may experience cancer disparities and these groups can be defined by age, gender, education, ethnicity, income, race, origin, and other characteristics. Health disparities can affect cancer outcomes, from diagnosis to treatment. This study evaluates the health disparities and outcomes of cancer patients in a Nigerian Teaching Hospital. Methods: This is a descriptive cross-sectional study using a structured questionnaire among patients visiting the oncology unit in the hospital. The questionnaire was interviewer- administered. Descriptive statistics was used to present respondents’ sociodemographic characteristics. Pearson correlation test was used to determine relationship between the determinant of cancer disparity (social demographics) and the outcomes (from patient perspective). Results: A total of 150 patients participated in the study. More female respondents (70%) than male respondents (45%), mostly within the age range of 62 and above (56.7%) participated in this study. The disparities examined include: age, gender, marital status, educational level, occupatina, montly income, religion and health insurance. There was a correlation between the different disparities and health outcomes. All disparities except gender were statistically significant (P = 0.05 & 0.01). Age, marital status, occupation status, religion and health insurance associated postively, while educational level and monthly income associated negatively. Gender had no associaton at all. Overall, patients (50%) were a little satisfied with the overall health outcomes.
- Open Access
- 7 June 2024
- Published by Sciencedomain International in Asian Journal of Research in Medical and Pharmaceutical Sciences
- Vol. 13 (3) , 61-76
Knowledge, Perception and Practice among Pharmacy Students Regarding Self-Medication in Eastern Nigeria: A Cross-Sectional Survey
Background: The prevalence of self-medication is increasing, not only among the general public but also among college and university students in the health field. Aim: This study aims to assess the knowledge, perception and practice of self-medication among pharmacy students in the university of Nigeria, Nsukka. Methods: This was a university-based cross-sectional study of 354 pharmacy students using a self-administered e-questionnaire. Data were summarized with descriptive statistics, chi square tests were used to assess association between the dependent and independent variables at a pResults: The prevalence of self-medication was 82% in this population. Among the respondents, 294(83.1%) demonstrated good knowledge of self-medication. Reasons for respondent’s practice of self-medication include; easy access to online treatment guidelines (39.5%), knowledge of therapy for minor ailments (36.4%), and time considerations (45.2%). The commonest classes of drugs used for self-medication by our respondents were; Antimalarials (85.9%), Antibiotics (74.9%), Analgesics (76.0%) and Gastrointestinals (59.6%). No significant association was found between students’ sociodemographic characteristics and their knowledge and practice of self-medication. Conclusion: While the pharmacy students demonstrated a remarkable understanding of self-medication, they frequently engaged in this harmful practice, particularly using antibiotics, antimalarials, and analgesics. This study highlights the need for a greater emphasis on antimicrobial stewardship and the dangers of self-medication in the pharmacy curriculum.
- 7 June 2024
- Published by Sciencedomain International in Asian Journal of Research in Medical and Pharmaceutical Sciences
- Vol. 13 (3) , 61-76
Open AccessKnowledge, Perception and Practice among Pharmacy Students Regarding Self-Medication in Eastern Nigeria: A Cross-Sectional Survey
Background: The prevalence of self-medication is increasing, not only among the general public but also among college and university students in the health field. Aim: This study aims to assess the knowledge, perception and practice of self-medication among pharmacy students in the university of Nigeria, Nsukka. Methods: This was a university-based cross-sectional study of 354 pharmacy students using a self-administered e-questionnaire. Data were summarized with descriptive statistics, chi square tests were used to assess association between the dependent and independent variables at a pResults: The prevalence of self-medication was 82% in this population. Among the respondents, 294(83.1%) demonstrated good knowledge of self-medication. Reasons for respondent’s practice of self-medication include; easy access to online treatment guidelines (39.5%), knowledge of therapy for minor ailments (36.4%), and time considerations (45.2%). The commonest classes of drugs used for self-medication by our respondents were; Antimalarials (85.9%), Antibiotics (74.9%), Analgesics (76.0%) and Gastrointestinals (59.6%). No significant association was found between students’ sociodemographic characteristics and their knowledge and practice of self-medication. Conclusion: While the pharmacy students demonstrated a remarkable understanding of self-medication, they frequently engaged in this harmful practice, particularly using antibiotics, antimalarials, and analgesics. This study highlights the need for a greater emphasis on antimicrobial stewardship and the dangers of self-medication in the pharmacy curriculum.
- Open Access
- 8 February 2023
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 9 (1) , 1-13
Assessment of pharmacovigilance activities among pharmacist interns in Nigeria: a cross-sectional study
Background: Pharmacovigilance (PV) and adverse drug reaction (ADR) reporting is at the core of the services and functions of a pharmacist. Pharmacist interns undergoing their one-year mandatory internship program are expected to be armed with this tool kit in order to provide adequate pharmaceutical services in all areas of pharmacy practice. Objectives: This study sought to assess the knowledge and perception of pharmacovigilance and adverse drug reaction reporting among pharmacist interns in Nigeria. Methods: This study was a cross-sectional study among pharmacist interns in their one-year mandatory internship program across Nigeria. The 32-item semi-structured questionnaires were administered online using simple random sampling with the snowballing technique to recruit the participants in the study. The results were analyzed with IBM SPSS version 25. Descriptive statistics were used to summarize the data. The Chi-square test and contingency coefficient were used to determine the association between knowledge of PV and the demographics of the participants. Results: A total of 450 pharmacist interns participated in this study. The participants' knowledge of pharmacovigilance and ADR is 92.5%. About 96.2% of respondents feel that responses to newly released pharmaceuticals must be recorded, compared to 79.1% for older drugs already on the market. There is a high correlation between the duration of the internship program and understanding of PV and ADR reporting among participants. More than fifty percent of respondents concur that ADR reporting is critical, while more than eighty percent concur that ADR reporting is required for pharmacists, the most significant health professionals in ADR reporting. The participants' length of participation in an internship program and their internship location significantly impact their opinion of ADR reporting. Seventy-four percent (74%) of respondents from tertiary hospitals say their internship center encourages ADR reporting. Conclusion: Most participants have a solid understanding of PV and ADR reporting, but perceptions of PV and ADR reporting are substantially correlated with internship location and program length. Active measures should be implemented to ensure that all pharmacy interns comprehend and embrace PV and ADR reporting as their exclusive duty.
- 8 February 2023
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 9 (1) , 1-13
Open AccessAssessment of pharmacovigilance activities among pharmacist interns in Nigeria: a cross-sectional study
Background: Pharmacovigilance (PV) and adverse drug reaction (ADR) reporting is at the core of the services and functions of a pharmacist. Pharmacist interns undergoing their one-year mandatory internship program are expected to be armed with this tool kit in order to provide adequate pharmaceutical services in all areas of pharmacy practice. Objectives: This study sought to assess the knowledge and perception of pharmacovigilance and adverse drug reaction reporting among pharmacist interns in Nigeria. Methods: This study was a cross-sectional study among pharmacist interns in their one-year mandatory internship program across Nigeria. The 32-item semi-structured questionnaires were administered online using simple random sampling with the snowballing technique to recruit the participants in the study. The results were analyzed with IBM SPSS version 25. Descriptive statistics were used to summarize the data. The Chi-square test and contingency coefficient were used to determine the association between knowledge of PV and the demographics of the participants. Results: A total of 450 pharmacist interns participated in this study. The participants' knowledge of pharmacovigilance and ADR is 92.5%. About 96.2% of respondents feel that responses to newly released pharmaceuticals must be recorded, compared to 79.1% for older drugs already on the market. There is a high correlation between the duration of the internship program and understanding of PV and ADR reporting among participants. More than fifty percent of respondents concur that ADR reporting is critical, while more than eighty percent concur that ADR reporting is required for pharmacists, the most significant health professionals in ADR reporting. The participants' length of participation in an internship program and their internship location significantly impact their opinion of ADR reporting. Seventy-four percent (74%) of respondents from tertiary hospitals say their internship center encourages ADR reporting. Conclusion: Most participants have a solid understanding of PV and ADR reporting, but perceptions of PV and ADR reporting are substantially correlated with internship location and program length. Active measures should be implemented to ensure that all pharmacy interns comprehend and embrace PV and ADR reporting as their exclusive duty.